Rome wasn't built in a day13 Sep 2018 08:46
I did say yesterday that this share is a good company and the poor trial was a factored in. The last paragraph of the RNS gives me a lot of confidence with the new drug. They feel they can still recoup information 're Japan. If it was a dud they would have dumped it. Be patient lol